Pfizer has launched its 20-valent pneumococcal conjugate vaccine (PCV20) in India, offering single-dose protection against 20 ...

Pfizer introduces its next-gen 20-valent pneumococcal conjugate vaccine (PCV20) in India for adult immunization against 20 ...

Single-dose PCV20 approved for adults 18 years and older, covering 20 pneumococcal serotypes, including both invasive and non ...

PCV20 will be available as a single-shot vaccine and those vaccinated with PCV20 may not need a second dose, the drug maker ...

Stocks like Highway Infrastructure, Hindalco Industries, Pfizer, Medi Assist, Adani Enterprises, and HG Infra Engineering ...

Pfizer has introduced its 20-valent pneumococcal conjugate vaccine, PCV20, in India to provide protection against 20 serotypes of pneumococcal disease. The single-shot vaccine is aimed at adults, ...

The NSE Nifty 50 ended 221.75 points or 0.91% higher at 24,585.05 and the BSE Sensex ended 746.29 points or 0.93% up at ...

Indian benchmarks indices, the BSE Sensex and NSE Nifty, are set to open in positive terrain on Tuesday, taking firm cues ...

Indian equity markets opened on a cautious note, a day after recording a sharp recovery that snapped a six-week losing streak ...

Indian equity markets closed in the green on Monday, boosted by gains by state-run banks, and real estate stocks in ...

PFIZER LTD - Launch Of Pneumococcal Polysaccharide Conjugate Vaccine (Adsorbed) I.P., 20 - Valent (PCV20) - Rediff MoneyWiz, the personal finance service from Rediff.com equips the user with tools and ...